CSIR-CCMB, Apollo Hospitals to jointly produce, commercialise COVID-19 test kits
The test kit has been developed by CSIR-CCMB and the collaboration with Apollo will focus on scaling up production and commercialisation of the tests jointly.
Share Via Email
| A+A A- By Express News Service
HYDERABAD: In what could be the gold standard for Covid-19 detection and make RT-PCR tests more affordable, the CSIR-Centre for Cellular & Molecular Biology (CCMB) and Apollo Hospitals Enterprise Ltd. announced a collaboration for joint manufacturing and commercialisation of an innovative dry swab test. Called the Direct Amplification rapid RT-PCR (DArRT-PCR) for SARS-CoV-2 detection, the test doesn’t require the viral transport medium, which is often more expensive and requires special handling.